# Bristol-Myers Squibb Company (BMY) — Q1-2019 Earnings Results

**Report date:** 2019-04-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q1-2019

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 2.29%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.10 | N/A | +0.05% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the earnings results, highlighting their commitment to innovation. They emphasized the importance of their ongoing projects and pipeline.

**Key quotes:**

> We are pleased with our performance this quarter.

> Our focus remains on delivering innovative therapies.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Bristol Myers Squibb's earnings report shows a slight beat on EPS, which contributed to a positive stock reaction, with shares rising by 2.29%. The management's cautious optimism suggests they are confident in their current strategies, even without providing specific guidance for the future. Investors may view this as a sign of stability amidst ongoing developments in their product pipeline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q1-2019_